Skip to main content Accessibility help

Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition

  • Shuaihua Pu (a1) (a2), Peter Eck (a1), David J. A. Jenkins (a3) (a4), Philip W. Connelly (a5) (a6), Benoît Lamarche (a7), Penny M. Kris-Etherton (a8), Sheila G. West (a8) (a9), Xiaoran Liu (a8) and Peter J. H. Jones (a1) (a2)...


Fatty acid ethanolamides (FAE), a group of lipid mediators derived from long-chain fatty acids (FA), mediate biological activities including activation of cannabinoid receptors, stimulation of fat oxidation and regulation of satiety. However, how circulating FAE levels are influenced by FA intake in humans remains unclear. The objective of the present study was to investigate the response of six major circulating FAE to various dietary oil treatments in a five-period, cross-over, randomised, double-blind, clinical study in volunteers with abdominal obesity. The treatment oils (60 g/12 552 kJ per d (60 g/3000 kcal per d)) provided for 30 d were as follows: conventional canola oil, high oleic canola oil, high oleic canola oil enriched with DHA, flax/safflower oil blend and corn/safflower oil blend. Two SNP associated with FAE degradation and synthesis were studied. Post-treatment results showed overall that plasma FAE levels were modulated by dietary FA and were positively correlated with corresponding plasma FA levels; minor allele (A) carriers of SNP rs324420 in gene fatty acid amide hydrolase produced higher circulating oleoylethanolamide (OEA) (P=0·0209) and docosahexaenoylethanolamide (DHEA) levels (P=0·0002). In addition, elevated plasma DHEA levels in response to DHA intake tended to be associated with lower plasma OEA levels and an increased gynoid fat mass. In summary, data suggest that the metabolic and physiological responses to dietary FA may be influenced via circulating FAE. Genetic analysis of rs324420 might help identify a sub-population that appears to benefit from increased consumption of DHA and oleic acid.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition
      Available formats


Corresponding author

* Corresponding author: P. J. Jones, fax +1 204 474 7552, email


Hide All
1. Epps, DE, Natarajan, V, Schmid, PC, et al. (1980) Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 618, 420430.
2. Devane, WA, Hanus, L, Breuer, A, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 19461949.
3. Marczylo, TH, Lam, PM, Amoako, AA, et al. (2010) Anandamide levels in human female reproductive tissues: solid-phase extraction and measurement by ultraperformance liquid chromatography tandem mass spectrometry. Anal Biochem 400, 155162.
4. Pasquariello, N, Catanzaro, G, Marzano, V, et al. (2009) Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis. J Biol Chem 284, 2941329426.
5. Pacher, P, Batkai, S & Kunos, G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58, 389462.
6. Romano, A, Coccurello, R, Giacovazzo, G, et al. (2014) Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite. Biomed Res Int 2014, 203425.
7. Fu, J, Gaetani, S, Oveisi, F, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 9093.
8. Lo Verme, J, Gaetani, S, Fu, J, et al. (2005) Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 62, 708716.
9. Hoareau, L, Buyse, M, Festy, F, et al. (2009) Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. Obesity (Silver Spring) 17, 431438.
10. Klein, TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5, 400411.
11. O’Sullivan, SE (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152, 576582.
12. Berger, A, Crozier, G, Bisogno, T, et al. (2001) Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A 98, 64026406.
13. Kim, HY, Moon, HS, Cao, D, et al. (2011) N-docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochem J 435, 327336.
14. Rahman, IA, Tsuboi, K, Uyama, T, et al. (2014) New players in the fatty acyl ethanolamide metabolism. Pharmacol Res 86, 110.
15. Tsuboi, K, Ikematsu, N, Uyama, T, et al. (2013) Biosynthetic pathways of bioactive N-acylethanolamines in brain. CNS Neurol Disord Drug Targets 12, 716.
16. Thabuis, C, Tissot-Favre, D, Bezelgues, JB, et al. (2008) Biological functions and metabolism of oleoylethanolamide. Lipids 43, 887894.
17. Sipe, JC, Waalen, J, Gerber, A, et al. (2005) Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes (Lond) 29, 755759.
18. Monteleone, P, Tortorella, A, Martiadis, V, et al. (2008) The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Psychoneuroendocrinology 33, 546550.
19. Jensen, DP, Andreasen, CH, Andersen, MK, et al. (2007) The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5801 whites. J Mol Med 85, 445449.
20. Monteleone, P, Milano, W, Petrella, C, et al. (2010) Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. J Clin Psychopharmacol 30, 441445.
21. Hariri, AR, Gorka, A, Hyde, LW, et al. (2009) Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry 66, 916.
22. Wangensteen, T, Akselsen, H, Holmen, J, et al. (2011) A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study). Obesity (Silver Spring) 19, 612617.
23. Geurts, L, Everard, A, Van Hul, M, et al. (2015) Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nat Commun 6, 6495.
24. Piers, LS, Walker, KZ, Stoney, RM, et al. (2003) Substitution of saturated with monounsaturated fat in a 4-week diet affects body weight and composition of overweight and obese men. Br J Nutr 90, 717727.
25. Moussavi, N, Gavino, V & Receveur, O (2008) Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring) 16, 715.
26. Pelkman, CL, Fishell, VK, Maddox, DH, et al. (2004) Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr 79, 204212.
27. Krishnan, S & Cooper, JA (2014) Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr 53, 691710.
28. Naughton, SS, Mathai, ML, Hryciw, DH, et al. (2013) Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism. Int J Endocrinol 2013, 361895.
29. Jones, PJ, Senanayake, VK, Pu, S, et al. (2014) DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am J Clin Nutr 100, 8897.
30. Senanayake, VK, Pu, S, Jenkins, DA, et al. (2014) Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola oil Multicenter Intervention Trial (COMIT). Trials 15, 136.
31. Mifflin, MD, St Jeor, ST, Hill, LA, et al. (1990) A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51, 241247.
32. Folch, J, Lees, M & Sloane Stanley, GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497509.
33. Lin, L, Yang, H & Jones, PJ (2012) Quantitative analysis of multiple fatty acid ethanolamides using ultra-performance liquid chromatography-tandem mass spectrometry. Prostaglandins Leukot Essent Fatty Acids 87, 189195.
34. Marczylo, TH, Lam, PM, Nallendran, V, et al. (2009) A solid-phase method for the extraction and measurement of anandamide from multiple human biomatrices. Anal Biochem 384, 106113.
35. Lin, L, Rideout, T, Yurkova, N, et al. (2013) Fatty acid ethanolamides modulate CD36-mRNA through dietary fatty acid manipulation in Syrian Golden hamsters. Appl Physiol Nutr Metab 38, 870878.
36. Jones, PJ, Lin, L, Gillingham, LG, et al. (2014) Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans. J Lipid Res 55, 26552664.
37. Pecina, M, Martinez-Jauand, M, Hodgkinson, C, et al. (2014) FAAH selectively influences placebo effects. Mol Psychiatry 19, 385391.
38. Tsuboi, K, Okamoto, Y, Ikematsu, N, et al. (2011) Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta 1811, 565577.
39. Simon, GM & Cravatt, BF (2010) Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo . Mol Biosyst 6, 14111418.
40. Blankman, JL & Cravatt, BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol Rev 65, 849871.
41. Muller, TD, Bronner, G, Wandolski, M, et al. (2010) Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity. BMC Med Gene 11, 2.
42. Yang, R, Fredman, G, Krishnamoorthy, S, et al. (2011) Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals. J Biol Chem 286, 3153231541.
43. Brown, I, Cascio, MG, Wahle, KW, et al. (2010) Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis 31, 15841591.
44. Wood, JT, Williams, JS, Pandarinathan, L, et al. (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51, 14161423.
45. Rashid, MA, Katakura, M, Kharebava, G, et al. (2013) N-docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. J Neurochem 125, 869884.
46. Ramsden, CE, Zamora, D, Makriyannis, A, et al. (2015) Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. J Pain 16, 707716.
47. Rodriguez de Fonseca, F, Navarro, M, Gomez, R, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414, 209212.
48. Joosten, MM, Balvers, MG, Verhoeckx, KC, et al. (2010) Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women. Nutr Metab (Lond) 7, 49.
49. Schmid, HH, Schmid, PC & Berdyshev, EV (2002) Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem Phys Lipids 121, 111134.
50. Aviello, G, Matias, I, Capasso, R, et al. (2008) Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. J Mol Med (Berl) 86, 413422.
51. Diep, TA, Madsen, AN, Holst, B, et al. (2011) Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J 25, 765774.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Type Description Title
Supplementary materials

Pu supplementary material
Figure S1

 Word (74 KB)
74 KB
Supplementary materials

Pu supplementary material
Table S1

 Word (12 KB)
12 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed